High independent prognostic and predictive value of circulating tumor cells compared with serum tumor markers in a large prospective trial in first-line chemotherapy for metastatic breast cancer patients

Cancer Patients ◽

Tumor Cells ◽

Predictive Value ◽

Prospective Trial ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Abstract PD2-03: Circulating tumor DNA (ctDNA) and circulating tumor cells (CTC) predictive value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: Results of a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

10.1158/1538-7445.sabcs18-pd2-03 ◽

2019 ◽

Author(s):

J-Y Pierga ◽

A Silveira ◽

V Lorgis ◽

M-L Tanguy ◽

O Tredan ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Predictive Value ◽

Metastatic Breast ◽

Circulating Tumor Dna ◽

Breast Cancer Patients ◽

First Line ◽

Tumor Dna

Abstract P1-01-02: Circulating tumor cells (CTC) and endothelial cells (CEC) prognostic value in HER2 negative metastatic breast cancer patients treated with first line weekly paclitaxel and bevacizumab: First results of a prospective cohort from the French Breast Cancer InterGroup Unicancer (UCBG): COMET study

10.1158/1538-7445.sabcs16-p1-01-02 ◽

2017 ◽

Author(s):

J-Y Pierga ◽

O Tredant ◽

M Chevrier ◽

C Dubot ◽

V Lorgis ◽

...

Keyword(s):

Breast Cancer ◽

Endothelial Cells ◽

Cancer Patients ◽

Tumor Cells ◽

Prognostic Value ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

First Results

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

Breast Cancer Research ◽

10.1186/bcr2907 ◽

2011 ◽

Vol 13 (3) ◽

Cited By ~ 141

Author(s):

Mario Giuliano ◽

Antonio Giordano ◽

Summer Jackson ◽

Kenneth R Hess ◽

Ugo De Giorgi ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Circulating Tumor Cells ◽

Systemic Treatment ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Prognostic And Predictive Markers

Carboplatin and docetaxel as first-line chemotherapy in metastatic breast cancer patients. Preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.862 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 862-862

Author(s):

M. E. Vassilomanolakis ◽

G. Koumakis ◽

V. Barbounis ◽

S. Demiris ◽

C. Panopoulos ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Preliminary Results ◽

First‐Line Chemotherapy for HER‐2–Negative Metastatic Breast Cancer Patients Who Received Anthracyclines as Adjuvant Treatment

The Oncologist ◽

10.1634/theoncologist.12-11-1288 ◽

2007 ◽

Vol 12 (11) ◽

pp. 1288-1298 ◽

Cited By ~ 10

Author(s):

Alessandro Morabito ◽

Maria Carmela Piccirillo ◽

Katia Monaco ◽

Carmen Pacilio ◽

Francesco Nuzzo ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Adjuvant Treatment ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Her 2 ◽

Docetaxel followed by capecitabine as first-line chemotherapy in metastatic breast cancer patients: preliminary results

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.854 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 854-854

Author(s):

J. Bayo ◽

J. Salvador ◽

M. Lomas ◽

M. Ruiz ◽

J. Baena ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Preliminary Results ◽

Abstract OT3-4-06: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for hormone receptors positive metastatic breast cancer patients: the STIC CTC METABREAST trial

10.1158/0008-5472.sabcs12-ot3-4-06 ◽

2012 ◽

Cited By ~ 1

Author(s):

F-C Bidard ◽

S Baffert ◽

D Hajage ◽

E Brain ◽

S Armanet ◽

...

Keyword(s):

Breast Cancer ◽

Cancer Patients ◽

Tumor Cells ◽

Hormone Receptors ◽

Metastatic Breast ◽

Line Treatment ◽

Breast Cancer Patients ◽

First Line ◽

First Line Treatment

Abstract 2410: Circulating tumor cells to guide the choice between chemotherapy and hormone therapy as first line treatment for metastatic breast cancer patients: the STIC CTC METABREAST trial.

10.1158/1538-7445.am2013-2410 ◽

2013 ◽

Cited By ~ 2

Author(s):

Jean-Yves Pierga ◽

Sandrine Baffert ◽

David Hajage ◽

Etienne Brain ◽

Sebastien Armanet ◽

...

Keyword(s):

Breast Cancer ◽

Hormone Therapy ◽

Cancer Patients ◽

Tumor Cells ◽

Metastatic Breast ◽

Line Treatment ◽

Breast Cancer Patients ◽

First Line ◽

First Line Treatment

Abstract P3-13-02: Phase II randomised clinical study of first line chemotherapy plus metformin versus first line chemotherapy alone in HER2 negative, non diabetic, metastatic breast cancer patients: Final results of the MYME study

10.1158/1538-7445.sabcs14-p3-13-02 ◽

2015 ◽

Cited By ~ 1

Author(s):

Alessandra Gennari ◽

Oriana Nanni ◽

Andrea DeCensi ◽

Samanta Sarti ◽

Andrea Freschi ◽

...

Keyword(s):

Breast Cancer ◽

Clinical Study ◽

Cancer Patients ◽

Phase Ii ◽

Metastatic Breast ◽

Breast Cancer Patients ◽

First Line ◽

Combination regimen of epirubicin, vinorelbine and 5-fluorouracil continuous infusion as first-line chemotherapy in anthracycline-naïve metastatic breast cancer patients

European Journal of Cancer ◽

10.1016/j.ejca.2004.07.003 ◽

2005 ◽

Vol 41 (2) ◽

pp. 249-255 ◽

Cited By ~ 5

Author(s):

Alfredo Berruti ◽

Raffaella Bitossi ◽

Alberto Bottini ◽

Simone Bonardi ◽

Michela Donadio ◽

...

Keyword(s):

Breast Cancer ◽

Continuous Infusion ◽

Cancer Patients ◽

Metastatic Breast ◽

Combination Regimen ◽

Breast Cancer Patients ◽

First Line ◽